Biotech News News 26 December 2025

Arcutis Biotherapeutics stock pops today as ARQT bucks biotech dip into year-end trade

NEW YORK, December 31, 2025, 10:33 ET — Regular session Shares of Arcutis Biotherapeutics Inc rose 3.8% to $29.16 by 10:33 a.m. ET on Wednesday, extending gains in the final U.S. trading session of 2025. The Nasdaq-listed dermatology drugmaker traded

31 December 2025

Biotech News·Financial Analysis·Investing·Pharmaceuticals·Stock Market

SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

NEW YORK, December 30, 2025, 15:25 ET — Regular session Scholar Rock Holding Corp (SRRK) slid 3.2% to $43.76 in afternoon trading on Tuesday after opening at $45.18. The stock traded between $45.95 and $43.74. The move matters because Scholar

30 December 2025

Biotech News·FDA Updates·Investment Analysis·Market Trends·Stock Market

Arcutis Biotherapeutics stock slides today as biotech pulls back, ARQT down nearly 3%

NEW YORK, December 30, 2025, 14:45 ET — Regular session Arcutis Biotherapeutics shares fell 2.9% to $27.74 in afternoon trading on Tuesday, after moving between $27.72 and $28.65. Volume was about 0.6 million shares. The drop outpaced broader biotech gauges,

30 December 2025

Biotech News·Company Updates·Financial Analysis·Investing·Stock Market

Vera Therapeutics stock drops 3% today as biotech slips into year-end trading

NEW YORK, December 30, 2025, 2:26 PM ET — Regular session Vera Therapeutics, Inc. shares slid 3.4% to $50.45 in afternoon trading on Tuesday, giving back some recent gains as biotech stocks softened late in the year. The move matters

30 December 2025

Biotech News·Financial Updates·Investing·Market Trends·Stock Market

GMAB stock slides as Genmab scraps late-stage acasunlimab cancer therapy

NEW YORK, December 30, 2025, 1:54 PM ET — Regular session Genmab A/S’s U.S.-listed shares (GMAB) fell 3.3% to $31.45 in Tuesday’s regular session. The stock traded between $31.40 and $32.06 after opening at $31.98, with about 1.9 million shares

30 December 2025

Biotech News·Cancer Research·Investment Analysis·Pharmaceutical Industry·Stock Market

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

NEW YORK, December 30, 2025, 13:14 ET — Regular session Corcept Therapeutics Inc shares fell 8.9% to $72.72 in early afternoon Nasdaq trading on Tuesday, after touching a session low of $72.26. The stock was last down $7.10 from Monday’s

30 December 2025

Biotech News·FDA Approvals·Investment Analysis·Pharmaceutical Industry·Stock Market

Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX

NEW YORK, December 30, 2025, 12:33 ET — Regular session Edgewise Therapeutics shares were up 0.2% at $24.68 as of 12:18 p.m. ET on Tuesday, after a Form 144 filing showed company officer Robert Michael Carruthers sold 116,665 shares worth

30 December 2025

Biotech News·Financial Updates·Insider Trading·Investment Analysis·Stock Market

Pfizer filings spotlight big portfolio shifts as Live Oak slashes stake 92%

NEW YORK, December 29, 2025, 10:35 ET Live Oak Private Wealth LLC cut its stake in Pfizer (PFE.N) by 92.5% in the third quarter, selling 216,868 shares and ending the period with 17,627 shares, a regulatory filing showed. MarketBeat The

29 December 2025

Biotech News·Company Analysis·Investments·Pharmaceuticals·Stock Market

Eli Lilly stock steadies into Monday as $55 million ABL Bio funding keeps pipeline in focus

NEW YORK, December 28, 2025, 20:34 ET — Market closed Eli Lilly shares ended the holiday week little changed after South Korean biotech ABL Bio said it would receive $55 million in funding from the U.S. drugmaker under a research

29 December 2025

Biotech News·Company Updates·Investment·Pharmaceuticals·Stock Market

Regencell Bioscience (RGC) Stock: What to Know After a Sharp Friday Slide, Latest Headlines, and the Setup for Monday

NEW YORK, Dec. 27, 2025, 7:48 PM ET — Market closed Regencell Bioscience Holdings Limited (Nasdaq: RGC) is heading into the final trading stretch of 2025 under a brighter spotlight after a volatile week capped by a steep Friday drop—one

28 December 2025

Biotech News·Financial Updates·Investing·Market Analysis·Stock Market

Regencell Bioscience (RGC) Stock Slides 14% Into the Weekend: Latest News, Risks, and What to Watch Monday

NEW YORK, Dec. 27, 2025, 6:40 a.m. ET — Market closed Regencell Bioscience Holdings Limited (NASDAQ: RGC) stock heads into the weekend after a sharp Friday pullback, closing at $21.16, down 13.98% from the prior close of $24.60, in a

27 December 2025

Biotech News·Financial Analysis·Investing·Stock Market

Edgewise Therapeutics (EWTX) Stock Today: EDG-7500 Safety Update, Analyst Targets, and What Investors Are Watching Next

NEW YORK — Friday, December 26, 2025 (1:07 p.m. ET). U.S. stocks are trading in a post-holiday session with major benchmarks close to flat, while biotech is notably weaker. Against that backdrop, Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is pulling back

26 December 2025

Biotech News·Company Updates·Investment Analysis·Investor Insights·Stock Market

Biotech News News 26 December 2025 - 31 December 2025